Supplements

Dexmedetomidine reduces perioperative neurocognitive disorders in older surgical patients

Dexmedetomidine is a pharmacologic agent extensively studied for perioperative neurocognitive disorders (PNDs) in older patients, with relatively strong supporting evidence. PNDs include postoperative delirium, delayed neurocognitive recovery, and long-term cognitive impairment, leading to prolonged hospital stay and reduced quality of life.

Last updated: Jul 9, 2026•0 RCTs•📖 Read as article →

Evidence Score

Evidence Score32/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★☆
Confidencelow

Study Evidence

Study 1. Perioperative neurocognitive disorders in older patients: a narrative review of current knowledge in 2026.

observational

Zhou X, Yang J, Tang Z, Yang S, Zhao H, Yang F · Perioperative medicine (London, England) (2026)

Participants: N/A
Duration: N/A
Intervention: Dexmedetomidine administration during perioperative period
Outcome: Incidence of perioperative neurocognitive disorders (postoperative delirium, delayed neurocognitive recovery, postoperative neurocognitive disorder, long-term cognitive impairment)
Effect Size: N/A
Population: Older surgical patients (age not specified, but implied 65+ years)

Result:

PubMed: 42399998DOI: 10.1186/s13741-026-00716-y

Mechanism Graph

Dexmedetomidine reduces neuroinflammation
↓
Attenuates oxidative stress
↓
Modulates gut microbiota dysbiosis
↓
Result: Lower incidence of PNDs

Limitations

  • ⚠Optimal intraoperative hemodynamic and anesthetic thresholds remain unclear
  • ⚠Causal links between delirium and long-term cognitive decline are not fully established
  • ⚠Clinical validation of biomarkers is still needed

Frequently Asked Questions

What are perioperative neurocognitive disorders (PNDs)?▼

PNDs are complications in older surgical patients including postoperative delirium, delayed neurocognitive recovery, postoperative neurocognitive disorder, and long-term cognitive impairment.

How does dexmedetomidine help prevent PNDs?▼

Dexmedetomidine is thought to reduce neuroinflammation, oxidative stress, and gut microbiota dysbiosis, which are core mechanisms of PNDs.

What are the key risk factors for PNDs?▼

Advanced age, preoperative cognitive impairment or frailty, intraoperative hypotension, deep anesthesia, hypothermia, cardiopulmonary bypass, and suboptimal postoperative pain and sleep control.

Is dexmedetomidine the only effective treatment for PNDs?▼

No, non-pharmacological interventions and multidisciplinary care are recommended as first-line strategies; dexmedetomidine has relatively strong supporting evidence but is not the sole option.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Zhou X, Yang J, Tang Z, Yang S, Zhao H, Yang F. "Perioperative neurocognitive disorders in older patients: a narrative review of current knowledge in 2026.." Perioperative medicine (London, England), 2026. PMID: 42399998 DOI: 10.1186/s13741-026-00716-y
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.